112 related articles for article (PubMed ID: 1709036)
1. Alteration of cellular oncogene expression in L1210 cells by a nitrosourea analog of thymidine.
Zhang XK; Zucker ML; Huang DP; Lin TS; Prusoff WH; Chiu JF
Cancer Commun; 1991 Apr; 3(4):119-26. PubMed ID: 1709036
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Cooper DL; Prusoff WH
Cancer Res; 1991 Mar; 51(6):1586-90. PubMed ID: 1900213
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
5. Calcium ionophore-induced transient down-regulation of c-myb mRNA levels in Friend erythroleukemia cells.
Schaefer A; Stöcker U; Marquardt H
J Biol Chem; 1993 May; 268(15):10876-80. PubMed ID: 8496152
[TBL] [Abstract][Full Text] [Related]
6. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
Weinberg JB; Mason SN
Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
[TBL] [Abstract][Full Text] [Related]
7. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Prusoff WH
Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
[TBL] [Abstract][Full Text] [Related]
8. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
Thiele CJ
Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
[No Abstract] [Full Text] [Related]
9. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression.
Sumitani K; Kamijo R; Nagumo M
Anticancer Res; 1997; 17(2A):865-71. PubMed ID: 9137419
[TBL] [Abstract][Full Text] [Related]
12. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
Selvakumaran M; Lin HK; Sjin RT; Reed JC; Liebermann DA; Hoffman B
Mol Cell Biol; 1994 Apr; 14(4):2352-60. PubMed ID: 8139540
[TBL] [Abstract][Full Text] [Related]
13. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the anticancer activity of bis(2-chloroethyl)nitrosourea in mice by coadministration of 2'-deoxyuridine, 2'-deoxycytidine, or thymidine.
Lin TS; Prusoff WH
Cancer Res; 1987 Jan; 47(2):394-7. PubMed ID: 3791229
[TBL] [Abstract][Full Text] [Related]
15. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.
Alleva DG; Askew D; Burger CJ; Elgert KD
Immunol Invest; 1994 Nov; 23(6-7):457-72. PubMed ID: 7851963
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias.
Wolff L; Koller R; Davidson W
J Virol; 1991 Jul; 65(7):3607-16. PubMed ID: 1645785
[TBL] [Abstract][Full Text] [Related]
18. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
19. A coordinated proto-oncogene expression characterizes MCF 247 murine leukemia virus-induced T-cell lymphomas irrespectively of proviral insertion affecting myc loci.
Boiocchi M; Dolcetti R; Maestro R; Feriotto G; Rizzo S; De Re V; Sonego F
Leuk Res; 1990; 14(6):549-58. PubMed ID: 1695700
[TBL] [Abstract][Full Text] [Related]
20. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
Toda I; Wickham LA; Sullivan DA
Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
